DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,321,183 | +1.4% | 29,509 | -1.9% | 0.58% | +5.2% |
| Q2 2023 | $7,221,360 | -7.5% | 30,089 | -2.8% | 0.55% | -10.8% |
| Q1 2023 | $7,805,426 | -12.5% | 30,969 | -7.9% | 0.62% | -12.9% |
| Q4 2022 | $8,924,747 | -0.8% | 33,625 | -3.5% | 0.71% | -8.0% |
| Q3 2022 | $8,997,000 | -0.2% | 34,836 | -2.0% | 0.78% | +7.5% |
| Q2 2022 | $9,011,000 | -4.4% | 35,542 | +10.7% | 0.72% | -14.7% |
| Q1 2022 | $9,421,000 | -23.5% | 32,117 | -14.2% | 0.84% | -19.1% |
| Q4 2021 | $12,309,000 | +5.2% | 37,412 | -2.7% | 1.04% | -4.5% |
| Q3 2021 | $11,701,000 | +10.7% | 38,432 | -2.4% | 1.09% | +11.4% |
| Q2 2021 | $10,568,000 | +14.0% | 39,381 | -4.4% | 0.98% | +8.9% |
| Q1 2021 | $9,274,000 | -1.1% | 41,203 | -2.4% | 0.90% | -4.0% |
| Q4 2020 | $9,380,000 | +3.4% | 42,227 | +0.3% | 0.94% | -6.2% |
| Q3 2020 | $9,069,000 | +14.7% | 42,114 | -5.8% | 1.00% | +9.6% |
| Q2 2020 | $7,906,000 | +42.6% | 44,710 | +11.6% | 0.91% | +22.2% |
| Q1 2020 | $5,544,000 | -1.8% | 40,052 | +8.9% | 0.75% | +21.2% |
| Q4 2019 | $5,643,000 | +41.6% | 36,764 | +33.3% | 0.62% | +33.3% |
| Q3 2019 | $3,984,000 | +8.6% | 27,584 | +7.4% | 0.46% | +8.4% |
| Q2 2019 | $3,670,000 | +8.9% | 25,677 | +0.6% | 0.43% | +5.7% |
| Q1 2019 | $3,371,000 | +28.9% | 25,536 | +0.6% | 0.40% | +16.1% |
| Q4 2018 | $2,616,000 | -5.4% | 25,372 | -0.3% | 0.35% | +10.8% |
| Q3 2018 | $2,764,000 | +4.2% | 25,438 | -5.3% | 0.31% | -1.9% |
| Q2 2018 | $2,652,000 | +1.1% | 26,868 | +0.3% | 0.32% | -0.3% |
| Q1 2018 | $2,623,000 | +2.6% | 26,785 | -2.7% | 0.32% | +7.7% |
| Q4 2017 | $2,556,000 | +8.3% | 27,538 | +0.1% | 0.30% | +4.2% |
| Q3 2017 | $2,361,000 | -8.0% | 27,524 | -9.4% | 0.29% | -7.1% |
| Q2 2017 | $2,565,000 | -10.3% | 30,396 | -9.0% | 0.31% | -7.8% |
| Q1 2017 | $2,858,000 | +5.0% | 33,407 | -4.5% | 0.33% | +11.3% |
| Q4 2016 | $2,722,000 | -0.2% | 34,977 | +0.5% | 0.30% | -2.9% |
| Q3 2016 | $2,728,000 | -25.9% | 34,806 | -4.6% | 0.31% | -27.8% |
| Q2 2016 | $3,683,000 | +5.7% | 36,466 | -0.7% | 0.43% | +0.7% |
| Q1 2016 | $3,483,000 | +0.8% | 36,716 | -1.4% | 0.42% | -2.1% |
| Q4 2015 | $3,457,000 | +11.6% | 37,220 | +2.4% | 0.43% | +5.6% |
| Q3 2015 | $3,097,000 | +2.8% | 36,354 | +3.2% | 0.41% | +12.3% |
| Q2 2015 | $3,014,000 | +2.6% | 35,216 | +1.8% | 0.37% | +2.8% |
| Q1 2015 | $2,937,000 | +1.6% | 34,589 | +2.6% | 0.36% | -1.4% |
| Q4 2014 | $2,890,000 | +13.6% | 33,713 | +0.7% | 0.36% | +10.7% |
| Q3 2014 | $2,543,000 | -4.5% | 33,477 | -1.1% | 0.33% | -2.4% |
| Q2 2014 | $2,663,000 | +4.1% | 33,835 | -0.8% | 0.33% | +1.5% |
| Q1 2014 | $2,559,000 | -2.6% | 34,122 | +0.3% | 0.33% | -3.5% |
| Q4 2013 | $2,627,000 | +9.2% | 34,031 | -1.9% | 0.34% | +1.2% |
| Q3 2013 | $2,405,000 | +5.4% | 34,692 | -3.8% | 0.34% | +2.1% |
| Q2 2013 | $2,282,000 | +19.5% | 36,045 | +17.3% | 0.33% | +13.0% |
| Q1 2013 | $1,910,000 | – | 30,724 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |